Global Long-Read Sequencing Services Market
Healthcare Services

Long-Read Sequencing Services Market Expansion Is Reshaping Competitive Dynamics Across The Industry

Enhanced with market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, The Business Research Company’s 2026 market reports deliver more actionable and strategically valuable research.

Long-Read Sequencing Services Market Growth Potential: How Will Market Size Change Through 2030?

The sector for long-read sequencing services has experienced substantial expansion recently. Projections indicate a progression from $1.18 billion in 2025 to $1.41 billion by 2026, reflecting a compound annual growth rate of 18.9%. Key drivers behind this growth in the preceding years include significant leaps in sequencing chemistry and instrumentation, augmented investment in genomic research initiatives, a mounting need for detailed genome analysis, the proliferation of large-scale academic genomics endeavors, and the emergence of dedicated providers offering specialized sequencing solutions.

The market for long-read sequencing services is poised for substantial expansion over the upcoming years, projected to reach $2.79 billion by 2030, signifying a compound annual growth rate of 18.6%. This anticipated surge is fueled by several key factors, including the escalating integration of long-read sequencing in clinical settings, augmented investments directed towards population genomics initiatives, the broadening scope of precision oncology research, a heightened requirement for novel genome assembly capabilities, and the incorporation of artificial intelligence for genomic interpretation. Throughout this forecast period, prominent trends are expected to shape the market, such as a greater emphasis on services for analyzing structural variations, increased utilization of nanopore sequencing technologies, a growing application of long-read sequencing in investigating rare diseases, the proliferation of clinical-grade long-read sequencing solutions, and a more concentrated effort on achieving thorough genome assembly.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=28260&type=smp

Long-Read Sequencing Services Market Growth Factors: Which Forces Are Supporting Market Expansion?

The increasing incidence of genetic conditions is anticipated to fuel the expansion of the long-read sequencing services sector. Genetic ailments, stemming from alterations or mutations in DNA that can be passed down or arise anew, impact an individual’s health, development, or bodily functions. This surge in genetic disease prevalence can be attributed to heightened public awareness and sophisticated diagnostic tools, which facilitate earlier and more precise identification of conditions previously overlooked. Long-read sequencing services play a crucial role in managing genetic disorders by delivering exceptionally accurate, extensive genomic information, thereby allowing for the exact identification of structural variations and intricate mutations. For example, as of April 2024, the National Institutes of Health (NIH), a leading American biomedical research institution, reported that approximately 6.9 million individuals aged 65 and above in the United States are presently affected by Alzheimer’s dementia, a number expected to approach 13.8 million by the year 2060. Consequently, the escalating occurrence of genetic disorders is a key driver for the growth observed in the long-read sequencing services market.

Long-Read Sequencing Services Market Segment Analysis Highlighting Growth Areas

The long-read sequencing services market covered in this report is segmented –

1) By Service Type: Whole Genome Sequencing, Targeted Sequencing, De Novo Sequencing, Other Services

2) By Technology: Single-Molecule Real-Time Sequencing, Nanopore Sequencing, Other Technologies

3) By Application: Clinical Diagnostics, Genomic Research, Oncology, Rare Disease Detection, Other Applications

4) By End User: Academic And Research Institutes, Hospitals And Clinics, Pharmaceutical And Biotechnology Companies, Other End-Users

Subsegments:

1) By Whole Genome Sequencing: Complete Genome Mapping, Comprehensive Variant Detection, Structural Variation Analysis, Comparative Genomics

2) By Targeted Sequencing: Gene Panel Sequencing, Exome Sequencing, Transcriptome Sequencing, Custom Target Region Sequencing

3) By De Novo Sequencing: Novel Genome Assembly, Structural Variant Characterization, Complex Genome Reconstruction, Non-Model Organism Sequencing

4) By Other Services: Data Analysis And Interpretation, Library Preparation Services, Bioinformatics Support Services, Validation And Quality Control Services

Long-Read Sequencing Services Market Industry Trends: What Changes Are Reshaping Demand?

Companies at the forefront of the long-read sequencing services sector are concentrating their efforts on pioneering advancements, including the development of primary template-directed amplification (PTA). This method facilitates high-accuracy, consistent amplification of the entire genome from solitary cells, thereby allowing for the sensitive identification of single-nucleotide variants (SNVs). Primary template-directed amplification represents a unique whole-genome amplification strategy engineered to precisely and uniformly amplify deoxyribonucleic acid (DNA) originating from trace amounts of sample material by reducing errors and safeguarding the integrity of the native DNA sequence. As an illustration, in October 2025, BioSkryb Genomics, Inc., a United States-based entity specializing in extended read sequencing technologies, introduced the ResolveSEQ LongRead Early Access Program. This state-of-the-art platform for single-cell whole-genome long-read sequencing combines primary template-directed amplification (PTA) with sophisticated long-read library preparation techniques to achieve thorough and consistent amplification from individual cells. Furthermore, this platform facilitates the precise detection of single-nucleotide variants (SNVs) and repeat expansions, while simultaneously offering haplotype phasing at the level of single cells.

Long-Read Sequencing Services Market Leading Companies: Who Holds Significant Market Presence?

Major companies operating in the long-read sequencing services market are Thermo Fisher Scientific Inc., Danaher Corporation, Agilent Technologies Inc., Illumina Inc., Revvity Inc., QIAGEN N.V., BGI Genomics Co. Ltd., Takara Bio Inc., Oxford Nanopore Technologies plc, Pacific Biosciences of California Inc., GENEWIZ Inc., Macrogen Inc., Novogene Co. Ltd., DNAnexus Inc., Zymo Research Corp., CD Genomics Inc., Genotypic Technology Pvt. Ltd., Plasmidsaurus Inc., BaseClear B.V., GrandOmics Biosciences Co. Ltd., Arima Genomics Inc., Wuhan Benagen Technology Co. Ltd.

Access The Complete Long-Read Sequencing Services Market Report:

https://www.thebusinessresearchcompany.com/report/long-read-sequencing-services-global-market-report

Long-Read Sequencing Services Market Regional Analysis: Which Region Leads By Revenue?

North Americawas the largest region in the long-read sequencing services market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the long-read sequencing services market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795

Asia: +44 7882 955267 & +91 8897263534

Europe: +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model